bioAffinity Technologies (BIAF) Return on Assets (2022 - 2026)

bioAffinity Technologies has disclosed Return on Assets across 5 years of filings, most recently posting 0.02% for Q1 2026.

• In Q1 2026, Return on Assets changed 0.0% year-over-year to 0.02%; the TTM figure through Mar 2026 stood at 0.02% (changed 0.0% YoY), while the FY2025 annual figure was 0.02%, changed 0.0% from the prior year.
• Return on Assets fell to 0.02% in Q1 2026, from 0.01% in the prior quarter.
• Over the last five years, Return on Assets for BIAF reached as high as 0.01% in Q4 2022 and fell as low as 0.02% in Q2 2025.
• The 5-year median for Return on Assets is 0.01% (2024), against an average of 0.01%.
• Annual changes were most pronounced in 2023 — Return on Assets changed 0 bps — and 2024, when it decreased 1 bps.
• A 5-year view of Return on Assets shows it stood at 0.01% in 2022, then plunged by 39 bps to 0.01% in 2023, then slumped by 60 bps to 0.01% in 2024, then grew by 4 bps to 0.01% in 2025, then dropped by 27 bps to 0.02% in 2026.
• According to Business Quant data, Return on Assets over the past three periods registered 0.02%, 0.01%, and 0.02% for Q1 2026, Q4 2025, and Q3 2025 respectively.